Cargando…

Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy

HMGB1 is a member of highly conserved high mobility group protein superfamily with intracellular and extracellular distribution. Abnormal HMGB1 levels are frequently manifested in various malignant diseases, including breast cancer. Numerous studies have revealed the clinical value of HMGB1 in the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Haonan, Zhang, Lu, Liu, Suling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134916/
https://www.ncbi.nlm.nih.gov/pubmed/35637945
http://dx.doi.org/10.7150/ijbs.73504